FindTrial
Sign In

Prediction of Oral Mucositis Risk in Nasopharyngeal Carcinoma Patients Receiving Radiotherapy

Construction of an Oral Mucositis Prediction Model for Nasopharyngeal Carcinoma Radiotherapy Based on Information Fusion

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500111461
Enrollment
Unknown
Registered
2025-10-31
Start date
2025-11-01
Completion date
Unknown
Last updated
2025-11-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Nasopharyngeal cancer

Interventions

Average oral dose > 30 gygroup:None
Average oral dose <= 30 gygroup:None

Sponsors

The Affiliated Hospital of Guangdong Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1.Pathologically confirmed nasopharyngeal carcinoma and planned to receive radiotherapy; 2.Aged >=18 years; 3.Having complete pre-radiotherapy CT images, radiotherapy planning data, and dose distribution files; 4.Receiving standardized RTOG grading evaluation of oral mucositis during radiotherapy; 5.Agreeing to the use of their de-identified data for scientific research and analysis.

Exclusion criteria

Exclusion criteria: 1.Presence of obvious oral mucosal ulcers or other oral diseases before radiotherapy that affect observation; 2.Patients undergoing retreatment who have received head and neck radiotherapy; 3.Radiotherapy interruption for more than 7 days; 4.Those with incomplete or poor-quality images or radiotherapy planning data.

Design outcomes

Primary

MeasureTime frame
Incidence of >=Grade 2 RIOM (NCI-CTCAE v5.0);—

Countries

China

Contacts

Public ContactLing Li

The Affiliated Hospital of Guangdong Medical University

liling1109@yeah.net+86 759 2387499

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026